Scarica l'app Stockscreener
331.07
0.69%
-2.4374
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PODD Giù?
Forum
Previsione
Precedente Chiudi:
$333.51
Aprire:
$333.51
Volume 24 ore:
215.55K
Relative Volume:
0.33
Capitalizzazione di mercato:
$23.31B
Reddito:
$2.36B
Utile/perdita netta:
$236.10M
Rapporto P/E:
100.63
EPS:
3.29
Flusso di cassa netto:
$382.50M
1 W Prestazione:
-3.10%
1M Prestazione:
+1.13%
6M Prestazione:
+24.59%
1 anno Prestazione:
+39.34%
Intervallo 1D:
$328.75
$333.71
Intervallo di 1 settimana:
$313.24
$345.74
Portata 52W:
$225.37
$353.50
Insulet Corporation Stock (PODD) Company Profile
Nome
Insulet Corporation
Settore
Industria
Telefono
978-600-7000
Indirizzo
100 NAGOG PARK, ACTON, MA
Confronta PODD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
331.19 | 23.48B | 2.36B | 236.10M | 382.50M | 3.29 |
|
ABT
Abbott Laboratories
|
136.19 | 234.21B | 43.11B | 13.94B | 6.78B | 7.98 |
|
SYK
Stryker Corp
|
379.19 | 144.45B | 23.82B | 2.92B | 4.02B | 7.55 |
|
BSX
Boston Scientific Corp
|
97.33 | 145.55B | 18.49B | 2.50B | 3.49B | 1.68 |
|
MDT
Medtronic Plc
|
95.39 | 122.61B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
74.43 | 43.77B | 5.69B | 1.41B | 577.90M | 6.95 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-08 | Ripresa | Oppenheimer | Outperform |
| 2025-06-16 | Iniziato | Truist | Buy |
| 2025-05-30 | Iniziato | Goldman | Buy |
| 2025-05-13 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-04-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2025-03-06 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-11-06 | Iniziato | Bernstein | Outperform |
| 2024-05-30 | Iniziato | Redburn Atlantic | Buy |
| 2024-05-07 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-12-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-08-21 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-08-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-01-26 | Iniziato | Wolfe Research | Peer Perform |
| 2022-11-04 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-07-11 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-03 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-02-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-01-31 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-07-21 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-01 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-07-28 | Iniziato | Wells Fargo | Overweight |
| 2020-04-24 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | Iniziato | BofA/Merrill | Neutral |
| 2020-03-31 | Downgrade | Berenberg | Buy → Hold |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2019-12-10 | Iniziato | CFRA | Sell |
| 2019-10-23 | Iniziato | Stifel | Hold |
| 2019-10-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | Downgrade | BTIG Research | Buy → Neutral |
| 2019-10-04 | Downgrade | UBS | Buy → Neutral |
| 2019-10-03 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-08-06 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-06-10 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2018-04-20 | Iniziato | Berenberg | Buy |
| 2018-02-22 | Reiterato | Barclays | Overweight |
| 2018-01-08 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | Iniziato | Barclays | Overweight |
Mostra tutto
Insulet Corporation Borsa (PODD) Ultime notizie
As biotech layoffs abound, medical device jobs are on the rise - The Business Journals
Marshall Financial Group LLC Takes Position in Insulet Corporation $PODD - MarketBeat
Alecta Tjanstepension Omsesidigt Boosts Position in Insulet Corporation $PODD - MarketBeat
Paladin Wealth LLC Invests $566,000 in Insulet Corporation $PODD - MarketBeat
Gradient Investments LLC Acquires New Position in Insulet Corporation $PODD - MarketBeat
Aaron Wealth Advisors LLC Takes $291,000 Position in Insulet Corporation $PODD - MarketBeat
Insulet Corporation $PODD Position Increased by Czech National Bank - MarketBeat
Swedbank AB Trims Stock Holdings in Insulet Corporation $PODD - MarketBeat
Inspire Investing LLC Has $1.08 Million Holdings in Insulet Corporation $PODD - MarketBeat
Aug Intraday: Can Insulet Corporation ride the EV waveJuly 2025 Institutional & Risk Managed Investment Entry Signals - khodrobank.com
Insulet (NASDAQ:PODD) Trading Down 4.2%Here's Why - MarketBeat
Insulet gets artistic with Omnipod Mango Pantone colour creation - Yahoo Finance
Piper Sandler Forecasts Strong Price Appreciation for Insulet (NASDAQ:PODD) Stock - MarketBeat
A Look At The Fair Value Of Insulet Corporation (NASDAQ:PODD) - Yahoo Finance
Insulet Corporation (PODD) Benefited from Omnipod Sales - uk.finance.yahoo.com
Insulet and Pantone create Omnipod Mango as official color - Investing.com
Insulet partners with Pantone to create Omnipod Mango color for insulin pumps - StreetInsider
Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette - Business Wire
United States Insulin Pump Market Expansion Driven by Diabetes - openPR.com
Financiere des Professionnels Fonds d investissement inc. Takes $543,000 Position in Insulet Corporation $PODD - MarketBeat
United Services Automobile Association Makes New Investment in Insulet Corporation $PODD - MarketBeat
Goldman Sachs Group Inc. Increases Stock Holdings in Insulet Corporation $PODD - MarketBeat
Sheets Smith Investment Management Boosts Holdings in Insulet Corporation $PODD - MarketBeat
Insulet Corporation $PODD Shares Sold by UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC - MarketBeat
Acadian Asset Management LLC Increases Stake in Insulet Corporation $PODD - MarketBeat
Insulet Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Will Insulet’s (PODD) New CFO Shape a Stronger Growth Path Amid Rising Revenue Guidance? - simplywall.st
Why Insulet (PODD) Shares Are Falling Today - Yahoo Finance
Insulet stock price target maintained at $365 by Truist on strong growth - Investing.com
Truist Securities Reiterates Buy Rating on Insulet Corporation (PODD), CFO transition seed as a modest surprise - StreetInsider
Insulet Corporation Azioni (PODD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Insulet Corporation Azioni (PODD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Singh Prem | SVP, Global Operations |
Sep 08 '25 |
Sale |
347.49 |
687 |
238,726 |
3,456 |
| Cousin Laetitia | SVP, Reg, Quality & Compliance |
Sep 08 '25 |
Option Exercise |
241.10 |
797 |
192,160 |
4,687 |
| Cousin Laetitia | SVP, Reg, Quality & Compliance |
Sep 08 '25 |
Sale |
348.81 |
797 |
278,002 |
3,890 |
0.30%
1.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):